Skip to main content

Table 1 Cost estimates

From: Transversus abdominis plane block with liposomal bupivacaine compared to oral opioids alone for acute postoperative pain after laparoscopic hysterectomy for early endometrial cancer: a cost-effectiveness analysis

Cost

Base-case ($)

Range (S)

Reference

30 day mortality

5000

2000–10,000

Assumed

Aspiration

30

0–100

UpToDate

Liposomal bupivacaine

204

50–350

UpToDate

Liposomal bupivacaine adverse event

209.76

100–300

CMS

Composite complication

18.72

10–30

UpToDate

Postoperative ileus

8296

1000–15,000

8

Oral opioids

16.23

10–25

UpToDate

Nonfatal bowel perforation

138,000

20,000–200,000

9

Readmission

10,000

5000–15,000

10

Laparoscopic hysterectomy

6679

5197–8673

6

Cost reduction for same-day discharge

2400

1000–4000

7

TAP procedure

83.12

75–100

CMS

TAP complication

315.70

200–450

CMS

  1. Abbreviations: CMS Centers for Medicare & Medicaid Services